drugset / Trial / NCT00773357
Modeling Stress-precipitated Smoking Behavior for Medication Development
Phase 2
Completed
100 enrolled
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collabNational Institute on Drug Abuse (NIDA) · collabOffice of Research on Women's Health (ORWH) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to examine whether guanfacine will attenuate the ability of stress to precipitate smoking lapse behavior in treatment seeking and non-treatment seeking daily smokers.
Timeline
- Start
- 2008-10
- Primary completion
- 2021-07-31
- Completion
- 2021-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guanfacine | Small molecule | 3 mg | — |
Indications
No indication recorded.